Neuropharmacological Interventions in Neurodegenerative Disorders

This track is dedicated to exploring pharmacological strategies for treating neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Researchers are encouraged to submit abstracts on novel drug candidates, mechanisms of action, and clinical trial results. The track will cover both symptomatic treatments and disease-modifying therapies, with a focus on advancing our understanding of neurodegenerative processes. Attendees will learn about the latest therapeutic approaches that aim to slow or halt the progression of these debilitating diseases.

    Related Conference of Neuropharmacological Interventions in Neurodegenerative Disorders

    March 17-18, 2025

    9th Global Summit onNephrology, Urology and Kidney Transplantation

    Singapore City, Singapore
    March 24-25, 2025

    21st World Nephrology Conference

    Amsterdam, Netherlands
    May 26-27, 2025

    29th European Nephrology Conference

    Rome, Italy
    June 23-24, 2025

    26th Global Nephrology, Urology and Kidney Failure Congress

    Aix-en-Provence, France

    Neuropharmacological Interventions in Neurodegenerative Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in